37th International Symposium on ALS/MND

Amsterdam, the Netherlands

Wednesday 9 December – Friday 11 December 2026

  • Home
  • About
    • About the event
    • Accreditation
    • Past Symposia
    • Future dates
    • Sign up for updates
  • Sponsors/Exhibitors
    • Sponsors
    • Exhibitors
  • Programme
    • Programme
    • Abstracts Online
    • Abstract Submission
  • Get Involved
    • Symposium Stories
    • Symposium Blogs
  • Register
  • Menu
Home » Symposium 2021 » What next for edaravone?

What next for edaravone?

Posted on by Symposium Admin

This blog will be published on 29th November 2021

Symp Blog coming soon

Posted in Symposium 2021.

Post navigation

← Update on clinical trials – part 2
Join us at the 32nd… →
logo
© 2026 MND Association: Registered in England at Francis Crick House, 6 Summerhouse Road, Moulton Park, Northampton, NN3 6BJ. Registered Charity no. 294354. VAT Registration no. 316 4340 28.
  • Contact
  • Sitemap
  • Cookies Policy
  • Privacy Policy
  • Terms and Conditions
  • Sign up for updates

Follow us

  • facebook
  • twitter
  • youtube
  • instagram
© 2026 MND Association: Registered in England at Francis Crick House, 6 Summerhouse Road, Moulton Park, Northampton, NN3 6BJ. Registered Charity no. 294354. VAT Registration no. 316 4340 28.
A SiteOrigin Theme